| Code | Description | Claims | Beneficiaries | Total Paid |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
308 |
290 |
$22K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
444 |
400 |
$16K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
261 |
222 |
$12K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
305 |
265 |
$10K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
173 |
163 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
851 |
385 |
$7K |
| 93040 |
|
339 |
319 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
240 |
222 |
$2K |
| S8301 |
Infection control supplies, not otherwise specified |
130 |
113 |
$829.58 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
83 |
65 |
$731.75 |
| 87807 |
|
35 |
32 |
$259.25 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
27 |
27 |
$4.57 |